Loading...

Jcancom's Recent CancerCompass Activity

  • Jcancom has replied to a post on the message board

    critic, is NKTR214 intended more as local treatment or whole body? Up till now many people have falsely celebrated the cure for cancer while not appreciating that curing a primary is not a cure. It might not even have any survival benefit. The results for NKTR214 seem great, though I am not sure what is being claimed for it at the whole body level.  

    April 01 at 3:49 PM view post
    • Jcancom has replied to a post on the message board

      critic, I am so grateful that Nk-214 is now on the horizon. Nk-214 is getting set to be tried in a wide range of cancer indications. For RCC and melanoma, it already has solid numbers; we will have to wait a while to see how it does with the others. It is almost impossible to imagine, though, if you actually look at the cancer statistics over the last many years mortality rates typically do not decrease even when ap...

      March 31 at 2:37 PM view post
      • Jcancom has replied to a post on the message board

        What a disappointment! Those who have followed our thread over all these years know that 3-BP has a large amount of potential. It would be hard to argue that there must be at least one of the many published formulations that could be of considerable help to patients, while also being safe. I am especially impressed with some of the more recently published work using nanoencapsulations. How is it that 3-BP has been w...

        March 19 at 12:01 AM view post
        • Jcancom has replied to a post on the message board

          Tobbie12, sorry to hear of your situation. I hope that the thread can help you. Over all these years on this thread it has been an adventure in learning about cancer and there have been many potentially powerful treatments discussed here. I greatly wish that we are now moving towards the finish line, however with the cancer mirage you are always moving closer to the finish line while it always seems farther away.&n...

          March 12 at 1:57 AM view post
          • Jcancom has replied to a post on the message board

            critic, thank you again! One company developing enzymes for all the cancer auxotrophs? Startling! I was especially interested in the cysteine/cystine product and how it related to glutathione. Other long term thread followers will see as I do here, the same players in cancer keep cropping up time and time again and will have an inkling that all the pieces are falling into place for highly specific and highly effecti...

            February 25 at 4:45 PM view post
            • Jcancom has replied to a post on the message board

              critic, yes the NKTR deal is huge! I did not want to mention it because I might have overdone my enthusiasm on my last post about 214, though with the latest deal perhaps my comments were on the mark. It is very impressive that as you noted it will be investigated in 9 tumor indications. Immunological drugs have a wider range of targets than I had anticipated. The feeling that I have now is that we are sprinting to ...

              February 17 at 5:52 PM view post
              • Jcancom has replied to a post on the message board

                Dear finder, I am surpised that the media has not yet recognized this as a potential story. It is probably even more surprising that the investigators have not moved ahead of such a story by making a preemptory statement about whatever has been determined so far about the potential of TLS in the Bracht incident. It would be important to clarify this because the entire nature of the investigation would greatly change...

                February 11 at 9:31 PM view post
                • Jcancom has replied to a post on the message board

                  finder, is there anything on this in the Dutch mediaspace? There is a growing glow on D's site. If Bracht was TLS, then it changes everything. The above url, "3-BP nicht verantwortlich" said it was not impure 3-BP. What then? TLS surely would then spring to mind. Have the investigators officially ruled out TLS? Would they be under a legal obligation to the community to make a timely disclosure if they had found evide...

                  February 09 at 12:28 AM view post
                  • Jcancom has replied to a post on the message board

                    I have refrained from commenting extensively on Bracht while the investigation has been ongoing. I wanted to give enough time for a thorough examination of the evidence. It has been almost two years and a report has yet to be produced. However, there appears to be an evolving understanding of what might have happened that I want to post. From url below:  "Medienberichten zufolge sollen Verunreinigungen von 3-B...

                    February 08 at 2:05 AM view post
                    • Jcancom has replied to a post on the message board

                      critic, you made my day again! A 100% DCR?!!! That is awesome! My ongoing comment about ccRCC is that it makes no sense to me. A ways back on the thread it was noted that ccRCC was found to have essentially no mitochondria!! How is it possible that kidney cancer can be somewhere near a top ten cancer type with clear cell RCC being the biggest subcomponent when it is so metabollically weak? The Scottish trial with ...

                      February 08 at 1:30 AM view post
                      Loading...
                      Load more activity
                      Loading more activity

                      About Jcancom

                      Jcancom has not shared any information about themselves. Send them a message to tell them you'd like to find out more about them or add them as a friend.

                      We care about your feedback. Let us know how we can improve your CancerCompass experience.